arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

MUSTANG BIO, INC.

MBIO

$0.58 0.00 (+0.68%) at close

11 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

MUSTANG BIO, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.8M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -25.9% ↘

FCF / Share $-1.07 ↗

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-1.92M

↑ +87.8% —

FCF / Share Free cash flow per share

$-1.07

↑ +94.3% —

Health Breakdown

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
EPS Growth YoY (%)	99.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	87.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	40.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-19814.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	87.8% Excellent ↑ Excellent Improving Year-over-year change in net income	69.5% Excellent ↑ Excellent Improving Year-over-year change in net income	33.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-16.8% Weak ↑ Weak Improving Year-over-year change in net income	-10.6% Weak ↑ Weak Improving Year-over-year change in net income	-29.4% Weak ↑ Weak Improving Year-over-year change in net income	-51.3% Weak ↑ Weak Improving Year-over-year change in net income	2.0% Caution Caution Year-over-year change in net income	-147.3% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	94.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	93.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	34.7% Excellent Excellent Year-over-year change in free cash flow	-20068.4% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Effective Tax Rate (%) (%)	-1.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	2.74x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	-25.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	331.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-31638.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-130.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-70.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-67.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-37.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-13.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-174.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-277.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-82.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-62.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-50.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-41.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-20.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	—	—	-167.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1217%)	-59.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-494%)	-61.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-506%)	-89.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-699%)	-84.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-662%)	-52.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-449%)	-52.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-448%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Debt to Equity (x)	—	—	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—
Interest Coverage (x)	—	-3249.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-11.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.67x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4448.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-25.97x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3902.88x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-3973.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	-12.70x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-17.27M	$-6.84M	$-6.23M	$-75.66M	$-109.62M	$-97.80M	$-60.16M	$-16.47M	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.03x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Basic EPS, GAAP (USD)	$-0.39	$-38.57	$-299.95	$-504.50	$-2.53	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.07	$-18.71	$-287.98	$-441.02	$-2.19	—	—	—	—	—	—
Book Value per Share (USD)	$1.94	$-6.35	$0.71	$301.08	$4.26	$69.36	$65.51	$68.35	$118.48	$80.00	$-103.17
Tangible Book Value per Share (USD)	$1.94	$-6.35	$0.71	$301.08	$4.26	$69.36	$65.51	$68.35	$118.48	$80.00	$-103.17
Basic Weighted Avg Shares (shares)	4.91M	609,696	172,031	153,690	26.37M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$9.68M	$-4.00M	$-4.03M	$63.74M	$100.89M	$90.02M	$55.29M	$29.51M	$57.75M	$24.28M	$-4.13M
Total Equity (USD)	$9.53M	$-3.87M	$123.00K	$46.27M	$112.40M	$98.44M	$51.65M	$36.40M	$59.83M	$24.28M	$-4.13M

📋 What is driving earnings? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗
Depreciation Expense (USD)	$34.00K	$671.00K	$1.86M	$2.72M	$2.17M	$1.68M	$1.26M	$630.00K	$2.00K	$0.00	—
Net Income, GAAP (USD)	$-1.92M	$-15.75M	$-51.60M	$-77.53M	$-66.37M	$-60.02M	$-46.39M	$-30.66M	$-31.29M	$-12.65M	—
Operating Cash Flow (USD)	$-5.26M	$-11.41M	$-49.48M	$-65.07M	$-53.67M	$-37.32M	$-33.58M	$-19.24M	$-12.95M	$-4.13M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 43 quarters

MUSTANG BIO, INC.

Analytical Summary

11-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare MBIO with peers